Immunohistochemical Expression of Heat Stable Antigen (CD24) in Renal Cell Carcinoma

Document Type : Review articles

Authors

Pathology department, Faculty of Medicine, Beni-Suef University, Egypt

Abstract

Renal cell carcinoma (RCC) is the most common type of urogenital cancer. It has a mortality rate of 30- 40% and is more commonly seen in men than women. Cluster of differentiation (CD)24 is a small, highly glycosylated cell adhesion protein that is normally expressed by immune cells as well as epithelial, neural, and muscle cells. Tumor CD24 expression had been linked with alterations in several oncogenic signaling pathways. The aim of our work to evaluate the immunohistochemical expression of CD24 in RCC and detect its relationship with other clinicopathological parameters. Thirty-nine (39) cases (97.5%) showed positive CD24 expression while single case (2.5%) was negative. Score 0 was seen in this single case (2.5%), score +1 was seen in 18 cases (45%), score +2 in 16 cases (40%) and score +3 was seen in 5 cases (12.5%). High CD24 expression had been presented in (52.5%) of cases. There was no significant correlation between CD24 expression and other clinicopathological parameters such as age, gender, histological subtype, tumor grade, pathological tumor stage, lymph node status, capsular invasion, tumor necrosis and lymphovascular emboli

Keywords

Main Subjects

References

  1. Jiang, W., Zeng, H., Liu, Z., Jin, K., Hu, B., Chang, Y., & Xu, J. (2022): Immune inactivation by CD47 expression predicts clinical outcomes and therapeutic responses in clear cell renal cell carcinoma patients. In Urologic Oncology: Seminars and Original Investigations 40 (4), 166-e15.
  2. Hsieh, J. J., Purdue, M. P., Signoretti, S., Swanton, C., Albiges, L., Schmidinger, M., & Ficarra, V. (2017): Renal cell carcinoma. Nature reviews Disease primers, 3(1), 1-19
  3. Mohebat, H. G., Mohammed, A. E., Nehal, S Z., Taghreed, A. E. & Elbaz, M. (2020): Chromophobe Renal Cell Carcinoma, Oncocytoma and Clear Cell Carcinoma A Compartive Immunohistochemical Study. The Medical Journal of Cairo University, 88(March), 103-110.
  4. Yamada, Y., Arai, T., Kato, M., Kojima, S., Sakamoto, S., Komiya, A., & Seki, N. (2019): Role of pre-miR-532 (miR-532-5p and miR-532-3p) in regulation of gene expression and molecular pathogenesis in renal cell carcinoma. American Journal of Clinical and Experimental Urology, 7(1), 11.
  5. Kabaria, R., Klaassen, Z., & Terris, M. K. (2016): Renal cell carcinoma: links and risks. International journal of nephrology and renovascular disease, 9, 45–52.
  6. Altevogt, P., Sammar, M., Hüser, L., & Kristiansen, G. (2021): Novel insights into the function of CD24: A driving force in cancer. International Journal of Cancer, 148(3), 546-559.
  7. Fang, X., Zheng, P., Tang, J., & Liu, Y. (2010): CD24: from A to Z. Cellular & molecular immunology, 7(2), 100-103.
  8. Moch, H., Cubilla, A. L., Humphrey, P. A., Reuter, V. E., & Ulbright, T. M. (2016): The 2016 WHO classification of tumours of the urinary system and male genital organs—part A: renal, penile, and testicular tumours. European urology, 70(1), 93-105.
  9. Lee, H. J., Kim, D. I., Kwak, C., Ku, J. H., & Moon, K. C. (2008): Expression of CD24 in clear cell renal cell carcinoma and its prognostic significance. Urology, 72(3), 603-607.
  10. Pallagani, L., Choudhary, G. R., Himanshu, P., Madduri, V. K., Singh, M., Gupta, P., & Sanjeev, M. (2021): Epidemiology and clinicopathological profile of renal cell carcinoma: a review from tertiary care referral centre. Journal of Kidney Cancer and VHL, 8(1), 1.
  11. Qu, Y., Chen, H., Gu, W., Gu, C., Zhang, H., Xu, J., & Ye, D. (2015): Age-dependent association between sex and renal cell carcinoma mortality: a population-based analysis. Scientific reports, 5(1), 9160.
  12. Arik, D., Can, C., Dündar, E., Kabukçuoğlu, S., & Paşaoğlu, Ö. (2017): Prognostic significance of CD24 in clear cell renal cell carcinoma. Pathology & Oncology Research, 23, 409-416.
  13. Godlewski, J., Stefaniak, P., Kiezun, J., & Krazinski, B. E. (2022): DNA polymerase Delta 1 catalytic subunit (POLD1) as a prognostic factor in clear cell renal cell carcinoma patients. in vivo, 36(3), 1188-1194.
  14. Wu, J., Zhang, P., Zhang, G., Wang, H., Gu, W., Dai, B., & Ye, D. (2017): Renal cell carcinoma histological subtype distribution differs by age, gender, and tumor size in coastal Chinese patients. Oncotarget, 8(42), 71797.
  15. Zanjani, L. S., Madjd, Z., Abolhasani, M., Rasti, A., Fodstad, O., Andersson, Y., & Asgari, M. (2018). Increased expression of CD44 is associated with more aggressive behavior in clear cell renal cell carcinoma. Biomarkers in Medicine, 12(1), 45-61.
  16. Droz, D., Zachar, D., Charbit, L., Gogusev, J., Chretein, Y., & Iris, L. (1990): Expression of the human nephron differentiation molecules in renal cell carcinomas. The American journal of pathology, 137(4), 895.

 

 

 

Files

Share

How to cite

Statistics